There are 2789 resources available
1268P - Real-time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Presenter: Marta Garcia De Herreros
Session: ePoster Display
1106P - Phase I study of hepatic intralesional rose bengal disodium (PV10), an autolytic immunotherapy, in metastatic neuroendocrine neoplasms
Presenter: Timothy Price
Session: ePoster Display
1107P - Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)
Presenter: Jaume Capdevila
Session: ePoster Display
1108P - Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas
Presenter: Baddar Pervaiz Butt
Session: ePoster Display
1109P - The psychological impact of COVID-19 pandemic on patients with NETs: Between resilience and vulnerability
Presenter: Eleonora Lauricella
Session: ePoster Display
1271P - Molecular driver mutations in never-smokers with lung adenocarcinoma
Presenter: Philip Mack
Session: ePoster Display
1272P - First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer
Presenter: Maria Jove Casulleras
Session: ePoster Display
1273P - Sputum supernatant as a viable liquid biopsy in advanced non-small cell lung cancer
Presenter: Chengzhi Zhou
Session: ePoster Display
1274P - An audit of liquid biopsies for NSCLC patients over a 50-month period in a resource constrained setting
Presenter: Navneet Singh
Session: ePoster Display